The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
Authors:
Open Access
- 21 February 2013
- journal article
- other
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 14 (1) , P200
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit: